For research use only. Not for therapeutic Use.
Acetohydroxamic Acid (Cat No.:A000042) is a urea-splitting enzyme inhibitor primarily used to treat chronic urinary tract infections caused by urease-producing bacteria. By inhibiting urease, AHA prevents the breakdown of urea into ammonia, which can contribute to kidney stone formation and promote bacterial growth. Its action helps maintain a stable urinary environment and reduces stone formation, especially in patients with recurring infections or catheter use. Additionally, AHA has been explored in cancer research for its potential to inhibit tumor growth, making it a versatile agent in clinical and research settings.
Catalog Number | A000042 |
CAS Number | 546-88-3 |
Synonyms | N-Hydroxyacetamide, Methylhydroxamic acid, Acetic acid|oxime, Lithostat |
Molecular Formula | C2H5NO2 |
Purity | ≥95% |
Target | Bacterial |
Storage | Store at +4C |
IUPAC Name | N-hydroxyacetamide |
InChI | InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4) |
InChIKey | RRUDCFGSUDOHDG-UHFFFAOYSA-N |
SMILES | CC(=O)NO |